Rachid Rafia MSc

Rachid Rafia

University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 213
West Court
Mappin Street
S1 4DP

Tel: (+44) (0)114 222 0739
Fax: (+44) (0)114 222 0749

E-mail: r.rafia@sheffield.ac.uk

ORCiD: 0000-0002-6914-1990


I joined ScHARR in February 2008, having completed a MSc in management of health care and health economics at the University Paris 1 Pantheon Sorbonne. I have worked as a health economic consultant and worked mainly on infectious diseases. Since joining ScHARR, I have gained experienced in modelling diseases such as Friedreich's ataxia, multiple sclerosis, soft tissue sarcoma, psoriatic arthritis, breast cancer, deep vein thrombosis and follicular lymphoma…etc. I was also involved in the modelling of the impact of reducing the blood alcohol concentration level in the England and Wales, extending breast cancer screening to older women and using GEP and IHC tests to help chemotherapy decision making in the UK.I am currently working on modelling breast cancer screening in the elderly. I have experience in model validation, critical appraisal and model development and have been involved in the Single Technology Appraisal (STA) process in terms of reviewing and critically appraising manufacturer’s submission for NICE (ovarian cancer, soft tissue sarcoma, deep vein thrombosis). I have also been involved in two Multiple Technology Appraisal (MTA) and a NICE diagnostic review (breast cancer diagnostics).

Research interests

My research interests are:

  • Health economics and economic evaluation
  • Health economic modelling for decision making

I am particularly interested in the economic evaluation of oncology treatments and infectious diseases

Teaching interests

I also teach on the distance learning Master in International Health Technology Assessment (iHTA) and supervise a master dissertation for the HEDM course.

My teaching interests are:

  • Health economics and economic evaluation
  • Health economic modelling for decision making

Current projects

I am currently working on the following projects:

  • Evaluating the cost-effectiveness of interventions looking at increasing hepatitis B vaccination uptake among injecting drug users
  • Modelling the cost-effectiveness of treatment in Myelofibrosis
  • Cost-benefit analysis of intervention for occupational asthma and rhinitis among bakery workers
  • provide guidance for the treatment of frailer older women with oestrogen receptor +ve breast cancer to ensure optimal treatment with either surgery (+adjuvant endocrine therapy) or primary endocrine therapy (PET).

Extended List of Publications

Journal articles